2020 / 01

Next Paper
DOI: 10.24075/brsmu.2020.005

CLINICAL CASE

Intolerance of preservative-containing eye drops in a glaucoma patient: diagnostic and therapeutic challenges

Frolov MA1, Kazakova KA1,2, Dushina GN1, Frolov AM1, Gonchar PA1
About authors

1 Peoples’ Friendship University of Russia, Moscow, Russia

2 Multiprofile Clinic “SM-Clinic”, Moscow, Russia

Correspondence should be addressed: Kseniya Kazakova
Miklouho-Maclay, 6, Moscow, 117198; ur.liam@inesk_averamonoP

About paper

Author contribution: Frolov MA — study planning; data analysis and interpretation; Kazakova KA, Dushina GN, Frolov AM, Gonchar PA — study planning; literature analysis; data acquisition, analysis and interpretation; manuscript preparation.

Received: 2019-12-26 Accepted: 2020-01-09 Published online: 2020-01-27
|
  1. Astahov SYu, Tkachenko NV. Taflotan — pervyj analog prostaglandina-F2α bez konservantov: preimushchestva v lechenii bol'nyh pervichnoj otkrytougol'noj glaukomoj. Oftal'mologicheskie vedomosti. 2016; 9 (2): 59–68.
  2. Egorov AE, Glazko NG, Movsisyan AB. Gipotenzivnaya i nejroprotektivnaya terapiya glaukomy: realii i perspektivy. Russkij medicinskij zhurnal. Klinicheskaya oftal'mologiya. 2019; 19 (3): 128–36.
  3. Yani EV, Seliverstova KE. Toksiko-allergicheskij kon"yunktivit u pacientov s pervichnoj glaukomoj na fone medikamentoznogo gipotenzivnogo lecheniya. Farmateka. 2016; 20 (333): 12–14.
  4. Erichev VP, Ambarcumyan KG, Fedorov A.A. Klinikomorfologicheskie dokazatel'stva vliyaniya konservantov na poverhnost' glaza pri pervichnoj otkrytougol'noj glaukome. Nacional'nyj zhurnal glaukoma. 2014; 13 (4): 13–22.
  5. Brzheskij VV, Radhuan M. Glaukoma i sindrom "suhogo glaza". Oftal'mologicheskie vedomosti. 2014; 7 (2): 37–49.
  6. Safonova TN, Fedorov AA, Zabegajlo AO, Egorova GB, Mitichkina TS. Lechenie sindroma "suhogo glaza" pri pervichnoj glaukome. Nacional'nyj zhurnal glaukoma. 2015; 14 (4): 36–43.
  7. Erichev VP, Ambarcumyan KG. Osobennosti gipotenzivnoj terapii bol'nyh glaukomoj preparatami, ne soderzhashchimi konservantov. Prakticheskaya medicina. 2012; 4 (59): 194–6. \
  8. Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefe’s Arch Clin Exp Ophthalmol. 2008; 246 (11): 1593–601.
  9. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008; 17 (5): 350–5.
  10. Astahov Syu, Graboveckij VR, Nefedova DM, Tkachenko NV. Preimushchestva i nedostatki gipotenzivnyh kapel' bez konservanta. Oftal'mologicheskie vedomosti. 2011; 4 (20): 95–97.
  11. Shtejner I, Branchevskij S. Problemy differencial'noj diagnostiki otsrochennoj allergicheskoj reakcii u pacientov, poluchajushhih mestnoe gipotenzivnoe lechenie glaukomy. Vrach. 2016; (12): 62–4.
  12. Alekseev IB, Koroleva IA. Beskonservantnye gipotenzivnye preparaty: preimushhestva terapii. Russkij medicinskij zhurnal. Klinicheskaja oftal'mologija. 2019; 19 (3): 137–42.
  13. Antonov AA, Kozlova IV, Mitichkina TS, Vedmedenko II. Beskonservantnaya terapiya glaukomy u pacientov, perenesshih keratorefrakcionnye operacii. Russkij medicinskij zhurnal. Klinicheskaya oftal'mologiya. 2019; 19 (3): 165–70.
  14. Loskutov IA, Korneeva AV. Beskonservantnaya forma fiksirovannoj kombinacii bimatoprosta i timolola v povyshenii komplaensa i effektivnosti lecheniya pacientov s pervichnoj otkrytougol'noj glaukomoj. Rossijskij oftal'mologicheskij zhurnal. 2018: 11 (2): 95–101.
  15. Onishchenko AL, Dimaksyan MV, Kolbasko AV, ZHilina NM. Lechenie pervichnoj otkrytougol'noj glaukomy β-ksololom bez konservanta: ocenka gipotenzivnogo effekta i glaznoj poverhnosti. Vestnik oftal'mologii. 2015; 131 (20): 76–80.
  16. Egorov EA. Novye formy selektivnyh β-blokatorov v lechenii glaukomy. Klinicheskaya oftal'mologiya. 2014; 14 (3): 131–5.
  17. Bourne R, Kaarniranta K, Lorenz K, Traverso CE, Vuorinen J, Ropo A. Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study. BMJ Open. 2019; 9 (4).
  18. Pillunat LE, Eschstruth P, Häsemeyer S, Thelen U, Foja C, Leaback R, et al. Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice. Clin Ophthalmol. 2016; 12 (10): 1759–65.